Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Hello monday might be our resume trading day !

<< Previous

Bullboard Posts

Next >>

Comment by JamesNeven1983on Nov 15, 2020 3:08pm

138 Views

Post# 31903505

RE:Hello monday might be our resume trading day !

Ok I see it but the link im clicking on isnt opening ... could you copy and paste please? Tried 4x to Open it so I can read it but for some reason this lame phone isnt letting me lol

Iber0star wrote:
look at the link bellow it cant be showed on the news page cause the compagny is actually halted but look at the top one news on sedar !!

https://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00021766

They apliccated to revoke the halt on the 10th. They might resume sooner or later.

My position if on warrants i got fews thousand k of them .

Let see what the future bring in !